AT333974B - Verfahren zur herstellung eines pulverformigen inhalationspraparates - Google Patents

Verfahren zur herstellung eines pulverformigen inhalationspraparates

Info

Publication number
AT333974B
AT333974B AT39073*#A AT39073A AT333974B AT 333974 B AT333974 B AT 333974B AT 39073 A AT39073 A AT 39073A AT 333974 B AT333974 B AT 333974B
Authority
AT
Austria
Prior art keywords
manufacturing
inhalation device
powder inhalation
powder
inhalation
Prior art date
Application number
AT39073*#A
Other languages
German (de)
English (en)
Other versions
ATA39073A (de
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36763080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT333974(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of ATA39073A publication Critical patent/ATA39073A/de
Application granted granted Critical
Publication of AT333974B publication Critical patent/AT333974B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT39073*#A 1971-08-10 1973-01-18 Verfahren zur herstellung eines pulverformigen inhalationspraparates AT333974B (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB3745671A GB1410588A (en) 1971-08-10 1971-08-10 Composition
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
ZA730284A ZA73284B (en) 1971-08-10 1973-01-15 Pharmaceutical powder composition containing sodium cromoglycate
AU51191/73A AU5119173A (en) 1971-08-10 1973-01-17 Composition
ES410910A ES410910A1 (es) 1971-08-10 1973-01-24 Un procedimiento para la preparacion de una composicion farmaceutica en polvo para inhalacion.

Publications (2)

Publication Number Publication Date
ATA39073A ATA39073A (de) 1976-04-15
AT333974B true AT333974B (de) 1976-12-27

Family

ID=36763080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT39073*#A AT333974B (de) 1971-08-10 1973-01-18 Verfahren zur herstellung eines pulverformigen inhalationspraparates

Country Status (19)

Country Link
US (1) US4009280A (OSRAM)
JP (1) JPS5652001B2 (OSRAM)
AT (1) AT333974B (OSRAM)
AU (1) AU5119173A (OSRAM)
CA (1) CA992461A (OSRAM)
DE (1) DE2239091A1 (OSRAM)
DK (2) DK131891C (OSRAM)
ES (1) ES410910A1 (OSRAM)
FI (1) FI56487C (OSRAM)
FR (1) FR2150759B1 (OSRAM)
GB (1) GB1410588A (OSRAM)
IE (1) IE37102B1 (OSRAM)
IL (1) IL39990A (OSRAM)
LU (1) LU66875A1 (OSRAM)
NL (1) NL7210780A (OSRAM)
NO (1) NO140747C (OSRAM)
SE (1) SE411842B (OSRAM)
ZA (1) ZA73284B (OSRAM)
ZM (1) ZM11971A1 (OSRAM)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5042819A (OSRAM) * 1973-08-20 1975-04-18
JPS5042827A (OSRAM) * 1973-08-20 1975-04-18
JPS5042826A (OSRAM) * 1973-08-20 1975-04-18
JPS6019043B2 (ja) * 1975-12-11 1985-05-14 ソニー株式会社 磁気再生装置
JPS5313111U (OSRAM) * 1976-07-16 1978-02-03
US4238502A (en) * 1978-08-03 1980-12-09 Fisons Limited Method of treating psychiatric conditions
BE891013A (fr) * 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
JP4526702B2 (ja) † 1997-09-29 2010-08-18 ネクター セラピューティックス 安定化生物活性処方物およびその使用方法
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
CA2382821A1 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7871598B1 (en) * 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AU2001280934A1 (en) * 2000-07-28 2002-02-13 Alliance Pharmaceutical Corp. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
EP1345629A2 (en) * 2000-12-29 2003-09-24 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
BR0207062A (pt) * 2001-02-06 2004-10-05 Innovata Biomed Ltd Composição farmacêutica bimodal, inalador para pó seco, método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino aos pulmões de um paciente, método de tratamento de um distúrbio respiratório, método de tratamento de doença pulmonar obstrutiva crÈnica (copd), uso de um agente antiinflamatório, uso de um broncodilatador, uso de uma mistura de um agente antiinflamatório e de um broncodilatador, e, processo para a fabricação de uma composição farmacêutica bimodal
EP1455755B1 (en) * 2001-11-20 2013-04-17 Civitas Therapeutics, Inc. Improved particulate compositions for pulmonary delivery
US20030129250A1 (en) * 2001-11-20 2003-07-10 Advanced Inhalation Research Inc. Particulate compositions for improving solubility of poorly soluble agents
ES2364636T3 (es) * 2001-12-19 2011-09-08 Novartis Ag Administración pulmonar de aminoglucósidos.
US6889690B2 (en) * 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
KR101657029B1 (ko) * 2008-07-24 2016-09-12 레르 리키드 쏘시에떼 아노님 뿌르 레드 에렉스뿔라따시옹 데 프로세데 조르즈 클로드 전이 금속 함유 필름의 침착을 위한 헤테로렙틱 시클로펜타디에닐 전이 금속 전구체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121096A (en) * 1961-12-27 1964-02-11 Roussel Uclaf New process of preparation of 3-methyl chromone
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
US3686412A (en) * 1965-03-25 1972-08-22 Colin Fitzmaurice Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190193A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1223690A (en) * 1967-10-17 1971-03-03 Fisons Pharmaceuticals Ltd Substituted chromon-2-carboxylic acids
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ZA73284B (en) 1973-11-28
NL7210780A (OSRAM) 1973-02-13
ES410910A1 (es) 1976-07-16
GB1410588A (en) 1975-10-22
FR2150759B1 (OSRAM) 1975-10-31
NO140747B (no) 1979-07-30
DK535774A (OSRAM) 1975-06-02
DK146974B (da) 1984-03-05
AU5119173A (en) 1974-07-18
FR2150759A1 (OSRAM) 1973-04-13
JPS5652001B2 (OSRAM) 1981-12-09
SE411842B (sv) 1980-02-11
ATA39073A (de) 1976-04-15
IE37102B1 (en) 1977-05-11
IL39990A0 (en) 1972-09-28
LU66875A1 (OSRAM) 1973-03-23
DK131891C (da) 1976-02-23
DK146974C (da) 1984-08-13
DE2239091A1 (de) 1973-02-22
DK131891B (da) 1975-09-22
CA992461A (en) 1976-07-06
IL39990A (en) 1977-02-28
NO140747C (no) 1979-11-07
FI56487C (fi) 1980-02-11
JPS4826764A (OSRAM) 1973-04-09
FI56487B (fi) 1979-10-31
US4009280A (en) 1977-02-22
ZM11971A1 (en) 1973-02-21

Similar Documents

Publication Publication Date Title
AT333974B (de) Verfahren zur herstellung eines pulverformigen inhalationspraparates
AT320296B (de) Verfahren zur Herstellung eines Pulvers
AT329186B (de) Verfahren zur herstellung eines gasfreien zahnputzmittels
AT318548B (de) Verfahren zur Herstellung eines Deshydratisierkatalysators
AT316756B (de) Verfahren zur herstellung eines lactulosepulvers
AT323628B (de) Verfahren zur herstellung eines gepressten gegenstandes
AT327661B (de) Verfahren zur herstellung eines sauermilchpulvers
AT329860B (de) Verfahren zur herstellung eines dispersionspulvers
AT305491B (de) Verfahren zur Herstellung eines neuen Kombinationspräparates
AT324511B (de) Verfahren zur herstellung eines überzugsmittels
AT319259B (de) Verfahren zur Herstellung neuer Dihydropyridazone
AT321230B (de) Verfahren zur Herstellung eines Enzym-Tannin-Adduktes
AT329271B (de) Verfahren zur herstellung eines modifizierten aminoplasten
AT312805B (de) Verfahren zur Herstellung eines Sekretin-Präparates
AT273636B (de) Verfahren zur Herstellung eines Präparates mit Fleischgeschmack
CH511877A (de) Verfahren zur Herstellung eines neuen Thiosemicarbazons
AT316706B (de) Verfahren zur Herstellung eines Überzugsmittels
AT332538B (de) Verfahren zur herstellung eines 7beta-aminocephalosporins
AT314736B (de) Verfahren zur herstellung eines lactulosepulvers
AT305496B (de) Verfahren zur Herstellung eines blutstillenden Präparats
CH537915A (de) Verfahren zur Herstellung eines neuen Östratriols
AT315368B (de) Verfahren zur Herstellung eines neuen Antibioticums
AT316753B (de) Verfahren zur Herstellung eines Fibrinolyseaktivators
AT297920B (de) Verfahren zur Herstellung eines Arzneimittels
AT312625B (de) Verfahren zur Herstellung eines neuen Oxazins

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee